Sumitovant Biopharma Ltd. is 10% Owner at Myovant Sciences Ltd. (MYOV). They have made 13 open-market trades across 2 companies since 2020, most recently 2021-09-28.
CIK 0001798244
13 open-market purchases totalling $32.9M since 2020, never a sale. Across 13 scored buys the stock is up 21.5% at ninety days, and 11.9 points ahead of the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 69% | 46% |
| Avg Move | +4.2% | +10.8% | +21.5% |
| Alpha | +3.4% | +8.8% | +11.9% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYOV | BUY | 2021-09-28 | 2021-09-30 | $22.85 | $945K | -6.2% | +2.3% | -27.2% |
| MYOV | BUY | 2021-09-24 | 2021-09-28 | $24.00 | $3.2M | -11.9% | -7.2% | -31.1% |
| MYOV | BUY | 2021-09-14 | 2021-09-16 | $22.03 | $7.1M | -0.1% | -10.2% | -32.8% |
| MYOV | BUY | 2021-09-03 | 2021-09-08 | $26.48 | $3.4M | -13.9% | -21.7% | -37.0% |
| MYOV | BUY | 2021-08-24 | 2021-08-26 | $22.40 | $2.8M | +13.8% | +4.5% | -12.2% |
| MYOV | BUY | 2021-08-20 | 2021-08-24 | $21.65 | $4.4M | +20.3% | +4.8% | -13.2% |
| MYOV | BUY | 2020-05-06 | 2020-05-11 | $12.24 | $612K | -2.2% | +31.4% | +23.9% |
| MYOV | BUY | 2020-04-29 | 2020-05-01 | $12.00 | $1.2M | +8.1% | +52.4% | +42.8% |
| MYOV | BUY | 2020-04-27 | 2020-04-29 | $12.13 | $1.6M | +9.1% | +3.6% | +37.3% |
| MYOV | BUY | 2020-04-15 | 2020-04-17 | $10.56 | $1.5M | +9.2% | +13.6% | +64.7% |
| MYOV | BUY | 2020-04-01 | 2020-04-03 | $7.60 | $1.1M | +25.6% | +38.3% | +137.0% |
| MYOV | BUY | 2020-03-24 | 2020-03-26 | $7.65 | $2.4M | -0.5% | +56.0% | +159.3% |
| UROV | BUY | 2020-02-19 | 2020-02-21 | $13.08 | $2.7M | +4.0% | -27.8% | -31.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.